Drug Shortage Report for PRAVASTATIN
| Report ID | 134025 |
| Drug Identification Number | 02389746 |
| Brand name | PRAVASTATIN |
| Common or Proper name | PRAVASTATIN |
| Company Name | SIVEM PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | PRAVASTATIN SODIUM |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 |
| ATC code | C10AA |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2020-11-30 |
| Estimated end date | 2021-03-22 |
| Actual end date | 2021-03-15 |
| Shortage status | Resolved |
| Updated date | 2021-03-23 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2021-03-23 | French | Compare |
| v5 | 2021-03-23 | English | Compare |
| v4 | 2021-03-02 | French | Compare |
| v3 | 2021-03-02 | English | Compare |
| v2 | 2021-02-12 | French | Compare |
| v1 | 2021-02-12 | English | Compare |
Showing 1 to 6 of 6